Atlas Trials

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

Clinical trial NCT00946751 · COMPLETED

Trial details

NCT number
NCT00946751
Sponsor
Sandoz
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Seizure
Start date
2004-03-01
Primary completion
2004-03-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.